The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry …

WY Yang, X Du, C Jiang, L He, AM Fawzy… - EP …, 2020 - academic.oup.com
… Our results indicate a low thromboembolic risk after successful AF ablation. Previous
history of IS/TIA/SE and diabetes mellitus were independently associated with an increased …

Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients

PL Lutsey, FL Norby, NA Zakai… - … medical research and …, 2019 - Taylor & Francis
… less effective for preventing VTE in … thromboembolic events in AF, some studies have
suggested poorer performance of rivaroxaban (vs dabigatran)Citation 45 , while other studies have

Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta‐analysis

A Lilli, A Di Cori, V Zaca - Clinical Cardiology, 2017 - Wiley Online Library
Anticoagulation with international normalized ratio–adjusted warfarin4 or with non–… ) oral
anticoagulants (NOACs) is highly effective in reducing the risk of stroke.4, 5 Whether the risk of …

Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation

L Smet, WA Heggermont, E Goossens… - Journal of advanced …, 2018 - Wiley Online Library
… Although RFA has proven to be effective in the treatment of AF, the risk for thromboembolic
events such as stroke increases substantially in patients, especially during the first month …

Stroke and thromboembolism prevention in atrial fibrillation

S Jame, G Barnes - Heart, 2020 - heart.bmj.com
… Since 2009, four direct oral anticoagulants (DOACs) have been compared with VKA therapy
Following ablation, regardless of the success of the procedure, there is consensus among …

Risk and management of bleeding complications with direct oral anticoagulants in patients with atrial fibrillation and venous thromboembolism: a narrative review

S Ballestri, E Romagnoli, D Arioli, V Coluccio… - Advances in …, 2023 - Springer
… In summary, DOACs have been found to be safer and more effective than warfarin for the …
on VTE treatment have shown that, for both young and elderly patients, DOACs have similar …

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

JM Rivera-Caravaca, V Roldán… - Thrombosis and …, 2017 - thieme-connect.com
Oral anticoagulation (OAC) is highly effective preventing … Oral anticoagulation use by patients
with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under…

Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation

T Hellman, T Kiviniemi, I Nuotio, T Vasankari… - Thrombosis …, 2017 - Elsevier
risk of thromboembolic complications after ECV performed during therapeutic oral anticoagulation
… higher temporary risk of thromboembolic complications after successful cardioversion. …

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

V Raparelli, M Proietti, R Cangemi… - Thrombosis and …, 2017 - thieme-connect.com
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular
atrial fibrillation … Non-vitamin K antagonist oral anticoagulants (NOACs) are as effective and …

Oral anticoagulation and the risk of stroke or death in patients with atrial fibrillation and one additional stroke risk factor: the Loire Valley Atrial Fibrillation Project

L Fauchier, C Lecoq, N Clementy, A Bernard… - Chest, 2016 - Elsevier
oral anticoagulation (OAC). We investigated the risk of ischemic stroke, systemic embolism,
… The subsequent step is to offer effective stroke prevention (ie, OAC) to patients with one or …